Computer Task Group (NASDAQ:CTG) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.17 by 47.06 percent. This is a 78.57 percent increase over earnings of $0.14 per share from the same period last year.
Orchard Therapeutics Announced Long-term Results From An Updated Integrated Analysis Of 39 Patients With Metachromatic Leukodystrophy Treated With Investigational OTL-200 In The Clinical Development Program
Administration of one-time gene therapy resulted in statistically significant improvement in severe motor impairment-free survival with up to 11 years of follow-up (median 6.15 years)
Composite primary endpoint used
